Study #PA13-0380
Radiogenomic Predictor for Pathologic Response and Recurrence in Esophageal Cancer Patients who Undergo Trimodality Therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Radiogenomic Esophageal Cancer
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Steven Lin
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.